Study to Assess the Immunogenicity and Safety of Etanercept Produced Using a Modified Process in Patients With Plaque Psoriasis
Public ClinicalTrials.gov record NCT02274792. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Single-arm Study to Assess the Immunogenicity and Safety of Etanercept Produced Using a Modified Process in Subjects With Plaque Psoriasis
Study identification
- NCT ID
- NCT02274792
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 4
- Lead sponsor
- Amgen
- Industry
- Enrollment
- 132 participants
Conditions and interventions
Conditions
Interventions
- Etanercept Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 125 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 31, 2014
- Primary completion
- Oct 31, 2015
- Completion
- Oct 31, 2015
- Last update posted
- Dec 28, 2016
2015
United States locations
- U.S. sites
- 33
- U.S. states
- 18
- U.S. cities
- 29
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Research Site | Mobile | Alabama | 36608 | — |
| Research Site | Bakersfield | California | 93309 | — |
| Research Site | Beverly Hills | California | 90212 | — |
| Research Site | Fremont | California | 94538 | — |
| Research Site | Los Angeles | California | 90036 | — |
| Research Site | Denver | Colorado | 80210 | — |
| Research Site | Denver | Colorado | 80220 | — |
| Research Site | Aventura | Florida | 33180 | — |
| Research Site | Miami | Florida | 33144 | — |
| Research Site | Pembroke Pines | Florida | 33028 | — |
| Research Site | Carmel | Indiana | 46032 | — |
| Research Site | Indianapolis | Indiana | 46256 | — |
| Research Site | New Albany | Indiana | 47150 | — |
| Research Site | Overland Park | Kansas | 66202 | — |
| Research Site | Overland Park | Kansas | 66215 | — |
| Research Site | Louisville | Kentucky | 40202 | — |
| Research Site | Owensboro | Kentucky | 42303 | — |
| Research Site | Rockville | Maryland | 20850 | — |
| Research Site | Andover | Massachusetts | 01810 | — |
| Research Site | Worcester | Massachusetts | 01605 | — |
| Research Site | Clarkston | Michigan | 48346 | — |
| Research Site | Omaha | Nebraska | 68144 | — |
| Research Site | Verona | New Jersey | 07044 | — |
| Research Site | Raleigh | North Carolina | 27612 | — |
| Research Site | Cincinnati | Ohio | 45249 | — |
| Research Site | Johnston | Rhode Island | 02919 | — |
| Research Site | Nashville | Tennessee | 37205 | — |
| Research Site | Bellaire | Texas | 77401 | — |
| Research Site | Dallas | Texas | 75230 | — |
| Research Site | Dallas | Texas | 75231 | — |
| Research Site | San Antonio | Texas | 78229 | — |
| Research Site | San Antonio | Texas | 78249 | — |
| Research Site | Norfolk | Virginia | 23507 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 12 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02274792, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 28, 2016 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02274792 live on ClinicalTrials.gov.